A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies

Key Points

• Bone marrow transplantation showed promising outcomes for patients with hematologic malignancies.
• The study targets HLA-partially to fully matched donors with significant improvements in transplant success.
• Assessment of deceased donor bone marrow transplantation provides new insights into treatment modalities.
• Findings highlight the need for continued exploration of allogeneic transplant strategies.